This information is for educational purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional.
OTC
Fulvestrant "SP"
(粉)
Data updated: 2026-04-25
Available in:
🇬🇧
Form
(粉)
Dosage
—
Route
—
Storage
—
About This Product
Manufacturer
台灣神隆股份有限公司 (TW)
Source
User Reviews
Reviews reflect personal experiences and are not medical advice. Always consult your doctor.
TFDA
(
ARTG
)
Fulvestrant-AFT is indicated for the treatment of postmenopausal women with:, Hormone receptor (HR) positive, human epidermal growth factor receptor 2 (HER2) negative, locally advanced or metastatic breast cancer who have not been previously treated with endocrine therapy., HR positive, locally advanced or metastatic breast cancer who have progressive disease following prior endocrine (anti-oestrogen or aromatase inhibitor) therapy.